In the News

Recent Coverage of HMS in the News
October 8, 2014

Claire McCarthy, assistant professor of pediatrics at Boston Children’s Hospital, authored this blog post about fighting Ebola.Read the full article

October 8, 2014

A new variation of a therapy used to treat X-linked severe combined immunodeficiency syndrome uses a genetically engineered virus to help the body create disease-fighting T-cells. David A. Williams, Leland Fikes Professor of Pediatrics at Boston Children’s Hospital, coauthored the study.

October 8, 2014

Scientists examining over-the-counter diet supplements are concerned about the inclusion of a new synthetic stimulant. Researchers testing several products found that the amount of the new stimulant varies widely, the dosage is not disclosed on labels and there is no evidence that the chemical is safe in humans. Pieter Cohen, assistant professor of medicine at Cambridge Health Alliance, led the research.Read the full article

October 8, 2014

Few women are on the list of doctors paid the most money by drug and medical device companies last year, according to a ProPublica analysis of new data released by the federal government. Anupam Jena, assistant professor of health care policy, is quoted. Read the full article

October 7, 2014

The Harvard Innovation Lab will kick off the Health and Life Sciences Challenge that will award innovative solutions in the fields of healthcare and the life sciences next Tuesday. Jeffrey S. Flier, dean of Harvard Medical School and Caroline Shields Walker Professor of Medicine, is co-chair of the Challenge committee. 

October 6, 2014

A 2003 rule restricting the number of hours doctors-in-training can work each week didn’t affect the quality of care they provided once they were practicing independently, suggests a new study. Anupam Jena, assistant professor of health care policy in the Department of Health Care Policy, led the research.Read the full article

October 6, 2014

Researchers with financial ties to flu drug companies more often reported positive findings in their studies of the treatments, a new analysis found. Florence Bourgeois, assistant professor of pediatrics at Boston Children’s Hospital, is a senior study author. Read the full article

October 6, 2014

Cancer treatments that genetically modify patients’ blood cells to target the disease have shown amazing results in clinical trials. Now drug companies and biotech’s must overcome big hurdles to get them into hospitals, including their potential cost. Daniel DeAngelo, associate professor of medicine at Dana-Farber Cancer Institute, is quoted.Read the full article


Submit Photo Requests to HMS
To request photos from the HMS Office of Communications and External Relations, click here.


Tell us about your awards
Share news of your achievements with the larger HMS community.  Click here.


Book Reviews
If you are a faculty member who has published a book recently, click here.